| 000 | 01808cam a2200205 4500 | ||
|---|---|---|---|
| 001 | 9780128120040 | ||
| 008 | 220107t2019 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9780128120040 | ||
| 020 | _a9780128120057 | ||
| 041 | _aeng | ||
| 100 | _aRay, Swapan K. | ||
| 245 | 0 | _aNeuroblastoma: molecular mechanisms and therapeutic interventions | |
| 260 |
_aLondon : _bAcademic Press, _c2019 |
||
| 300 | _a1 online resource (x, 323 pages):illustrations (some color) | ||
| 505 | _aNeuroblastoma pathology and classification -- Role of genetic and epigenetic alterations in pathogenesis of neuroblastoma -- Neuroblastoma molecular biology and promising therapeutic targets -- The GD2-targeted immunotherapy of neuroblastoma -- Targeting angiogenesis in neuroblastoma -- Autophagy and novel therapeutic strategies in neuroblastoma -- Energy metabolism and new therapeutic opportunities in neuroblastoma -- Multimodality imaging for diagnosis of neuroblastoma -- Immunotherapy for neuroblastoma -- Advances in surgical treatment of neuroblastoma -- Role of stemness factors in neuroblastoma: Neuroblastoma stem cells, tumor microenvironment, and chemoresistance -- Current pharmacotherapy for neuroblastoma -- Current challenges in the management of neuroblastoma -- Novel therapeutic targets in neuroblastoma -- Current and future strategies for treatment of relapsed neuroblastoma -- Current evidence in favor of a tumor suppressor role of KruÌppel-like factor 4 in malignant neuroblastoma -- Modulation of expression of microRNA as a therapeutic strategy in malignant neuroblastoma." | ||
| 690 |
_aNeuroblastoma. _97116 |
||
| 690 |
_aNeuroblastoma _97116 |
||
| 856 | _uhttps://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20160025780 | ||
| 999 |
_c58941 _d58941 |
||